English

Bioverativ Inc.

EDGAR

Filing amendment (SC 13G/A) · filed 2018-04-10

118 filing records in this dataset, filed from 2016-12-22 to 2018-04-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

329 million Unit1

2017 Q4 · Unit1

Exact inputs and evidence

Revenue: 328700000 Unit1 Source

Operating margin

35.87%

2017 Q4 · %

Exact inputs and evidence

Operating Income: 447200000 Unit1 Source
Operating Income: 329300000 Unit1 Source
Revenue: 328700000 Unit1 Source

Operating cash flow

213 million Unit1

2017 Q4 · Unit1

Exact inputs and evidence

Operating Cash Flow: 590700000 Unit1 Source
Operating Cash Flow: 377600000 Unit1 Source

Free cash flow

212 million Unit1

2017 Q4 · Unit1

Exact inputs and evidence

Operating Cash Flow: 590700000 Unit1 Source
Operating Cash Flow: 377600000 Unit1 Source
Capital Expenditure: 13100000 Unit1 Source
Capital Expenditure: 11600000 Unit1 Source

Cash and cash equivalents: 437 million Unit1 2017-12-31 Source
Exact value

436500000 Unit1
Long-term debt including current maturities: Not available
Shares outstanding: 108 million Unit14 2017-12-31 Source
Exact value

108203439 Unit14

Reported share-count change

10,820,243.90% · 108 million Unit14

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

1000 Unit14 · 2016-12-31· Source
108203439 Unit14 · 2017-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.17 billion Unit1

2017-01-01 – 2017-12-31

Exact inputs and evidence

Revenue: 259100000 Unit1 · 2017-01-01 – 2017-03-31 Source
Revenue: 289100000 Unit1 · 2017-04-01 – 2017-06-30 Source
Revenue: 291600000 Unit1 · 2017-07-01 – 2017-09-30 Source
Revenue: 328700000 Unit1 · 2017-10-01 – 2017-12-31 Source

Net income

356 million Unit1

2017-01-01 – 2017-12-31

Exact inputs and evidence

Net income: 69300000 Unit1 · 2017-01-01 – 2017-03-31 Source
Net income: 77100000 Unit1 · 2017-04-01 – 2017-06-30 Source
Net income: 67900000 Unit1 · 2017-07-01 – 2017-09-30 Source
Net income: 141300000 Unit1 · 2017-10-01 – 2017-12-31 Source

Operating cash flow

591 million Unit1

2017-01-01 – 2017-12-31

Exact inputs and evidence

Operating cash flow: 108200000 Unit1 · 2017-01-01 – 2017-03-31 Source
Operating cash flow: 241400000 Unit1 · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 108200000 Unit1 · 2017-01-01 – 2017-03-31 Source
Operating cash flow: 377600000 Unit1 · 2017-01-01 – 2017-09-30 Source
Operating cash flow: 241400000 Unit1 · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 590700000 Unit1 · 2017-01-01 – 2017-12-31 Source
Operating cash flow: 377600000 Unit1 · 2017-01-01 – 2017-09-30 Source

Capital expenditure

13.1 million Unit1

2017-01-01 – 2017-12-31

Exact inputs and evidence

Capital expenditure: 6300000 Unit1 · 2017-01-01 – 2017-03-31 Source
Capital expenditure: 10600000 Unit1 · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 6300000 Unit1 · 2017-01-01 – 2017-03-31 Source
Capital expenditure: 11600000 Unit1 · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 10600000 Unit1 · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 13100000 Unit1 · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 11600000 Unit1 · 2017-01-01 – 2017-09-30 Source

Free cash flow

578 million Unit1

2017-01-01 – 2017-12-31

Exact inputs and evidence

Operating cash flow: 108200000 Unit1 · 2017-01-01 – 2017-03-31 Source
Operating cash flow: 241400000 Unit1 · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 108200000 Unit1 · 2017-01-01 – 2017-03-31 Source
Operating cash flow: 377600000 Unit1 · 2017-01-01 – 2017-09-30 Source
Operating cash flow: 241400000 Unit1 · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 590700000 Unit1 · 2017-01-01 – 2017-12-31 Source
Operating cash flow: 377600000 Unit1 · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 6300000 Unit1 · 2017-01-01 – 2017-03-31 Source
Capital expenditure: 10600000 Unit1 · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 6300000 Unit1 · 2017-01-01 – 2017-03-31 Source
Capital expenditure: 11600000 Unit1 · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 10600000 Unit1 · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 13100000 Unit1 · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 11600000 Unit1 · 2017-01-01 – 2017-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-04-10.

Financial data available through: 2017-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2017-12-31
Operating income: 3 of 11 periods available· newest 2017-12-31
Net income: 3 of 11 periods available· newest 2017-12-31
Operating cash flow: 3 of 11 periods available· newest 2017-12-31
Capital expenditure: 3 of 11 periods available· newest 2017-12-31
Total assets: 2 of 11 periods available· newest 2017-12-31
Total liabilities: 2 of 11 periods available· newest 2017-12-31
Current assets: 2 of 11 periods available· newest 2017-12-31
Current liabilities: 2 of 11 periods available· newest 2017-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2017-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2017-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+31.7%

Prior period

Unit1 887.4 million

2016-01-01 – 2016-12-31
Current period

Unit1 1.17 billion

2017-01-01 – 2017-12-31

Exact inputs and evidence

1168500000 − 887400000 = 281100000 Unit1

887400000 Unit1 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
1168500000 Unit1 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Bioverativ Inc. · 2017-12-31 Bioverativ Inc. (edgar:1681689) Year-over-year change in Revenue: 281100000 Unit1 Concept: fundies:Revenue Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1168500000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1522688 Filing: 000155837018000672 Input fundies:Revenue: 887400000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1522070 Filing: 000155837018000672
The citation records this snapshot. The page link may show a newer release later.
Net income
-19.1%

Prior period

Unit1 439.6 million

2016-01-01 – 2016-12-31
Current period

Unit1 355.6 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

355600000 − 439600000 = -84000000 Unit1

439600000 Unit1 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
355600000 Unit1 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Bioverativ Inc. · 2017-12-31 Bioverativ Inc. (edgar:1681689) Year-over-year change in Net income: -84000000 Unit1 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 355600000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1196931 Filing: 000155837018000672 Input fundies:NetIncome: 439600000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1196056 Filing: 000155837018000672
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+95.9%

Prior period

Unit1 301.6 million

2016-01-01 – 2016-12-31
Current period

Unit1 590.7 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

590700000 − 301600000 = 289100000 Unit1

301600000 Unit1 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
590700000 Unit1 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Bioverativ Inc. · 2017-12-31 Bioverativ Inc. (edgar:1681689) Year-over-year change in Operating cash flow: 289100000 Unit1 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 590700000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195598 Filing: 000155837018000672 Input fundies:OperatingCashFlow: 301600000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195406 Filing: 000155837018000672
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+50.6%

Prior period

Unit1 8.7 million

2016-01-01 – 2016-12-31
Current period

Unit1 13.1 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

13100000 − 8700000 = 4400000 Unit1

8700000 Unit1 · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
13100000 Unit1 · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Bioverativ Inc. · 2017-12-31 Bioverativ Inc. (edgar:1681689) Year-over-year change in Capital expenditure: 4400000 Unit1 Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13100000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1259172 Filing: 000155837018000672 Input fundies:CapitalExpenditure: 8700000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1258982 Filing: 000155837018000672
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

Revenue Unit1 1.17 billion 100% of revenue
Cost of revenue Unit1 279.6 million 24% of revenue
Operating expenses Unit1 441.7 million 38% of revenue
Operating income Unit1 447.2 million 38% of revenue
Tax, interest and other Derived Unit1 91.6 million 7.8% of revenue
Net income Unit1 355.6 million 30% of revenue

Cash

Operating cash flow Unit1 590.7 million 51% of revenue
Capital expenditure Unit1 13.1 million 1.1% of revenue
Free cash flow Derived Unit1 577.6 million 49% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Net income was higher than operating income, so the split is not drawn.
2016 Net income was higher than operating income, so the split is not drawn.
2017 30%62%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	560300000	462300000 Derived	98000000	-10600000 Derived	108600000	30800000 Derived	Source 2015-01-01 – 2015-12-31: 560300000 Unit1 Inspect Revenue Open source 2015-01-01 – 2015-12-31: 98000000 Unit1 Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 108600000 Unit1 Inspect Net Income Open source 2015-01-01 – 2015-12-31: 41400000 Unit1 Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 10600000 Unit1 Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	887400000	595000000 Derived	292400000	-147200000 Derived	439600000	292900000 Derived	Source 2016-01-01 – 2016-12-31: 887400000 Unit1 Inspect Revenue Open source 2016-01-01 – 2016-12-31: 292400000 Unit1 Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 439600000 Unit1 Inspect Net Income Open source 2016-01-01 – 2016-12-31: 301600000 Unit1 Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 8700000 Unit1 Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	1168500000	721300000 Derived	447200000	91600000 Derived	355600000	577600000 Derived	Source 2017-01-01 – 2017-12-31: 1168500000 Unit1 Inspect Revenue Open source 2017-01-01 – 2017-12-31: 447200000 Unit1 Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 355600000 Unit1 Inspect Net Income Open source 2017-01-01 – 2017-12-31: 590700000 Unit1 Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 13100000 Unit1 Inspect Capital Expenditure Open source

Amounts are exact, in Unit1.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit1 1.2B 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit1)	Source evidence
20152015-12-31	Revenue	560300000	Revenue: 560300000 Open source
20162016-12-31	Revenue	887400000	Revenue: 887400000 Open source
20172017-12-31	Revenue	1168500000	Revenue: 1168500000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

31.7% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 560300000 Open source
20162016-12-31	Year over year	58.4%	Revenue: 887400000 Open source Revenue: 560300000 Open source
20172017-12-31	Year over year	31.7%	Revenue: 1168500000 Open source Revenue: 887400000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 38.3% 2017

Net margin 30.4% 2017

Free cash flow margin 49.4% 2017

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	17.5%	Operating Income: 98000000 Open source Revenue: 560300000 Open source
20162016-12-31	Operating margin	33%	Operating Income: 292400000 Open source Revenue: 887400000 Open source
20172017-12-31	Operating margin	38.3%	Operating Income: 447200000 Open source Revenue: 1168500000 Open source
20152015-12-31	Net margin	19.4%	Net Income: 108600000 Open source Revenue: 560300000 Open source
20162016-12-31	Net margin	49.5%	Net Income: 439600000 Open source Revenue: 887400000 Open source
20172017-12-31	Net margin	30.4%	Net Income: 355600000 Open source Revenue: 1168500000 Open source
20152015-12-31	Free cash flow margin	5.5%	Revenue: 560300000 Open source Operating Cash Flow: 41400000 Open source Capital Expenditure: 10600000 Open source
20162016-12-31	Free cash flow margin	33%	Revenue: 887400000 Open source Operating Cash Flow: 301600000 Open source Capital Expenditure: 8700000 Open source
20172017-12-31	Free cash flow margin	49.4%	Revenue: 1168500000 Open source Operating Cash Flow: 590700000 Open source Capital Expenditure: 13100000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit1 590.7M 2017

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit1)	Source evidence
20152015-12-31	Operating cash flow	41400000	Operating Cash Flow: 41400000 Open source
20162016-12-31	Operating cash flow	301600000	Operating Cash Flow: 301600000 Open source
20172017-12-31	Operating cash flow	590700000	Operating Cash Flow: 590700000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit1 577.6M 2017

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit1)	Source evidence
20152015-12-31	Free cash flow	30800000	Operating Cash Flow: 41400000 Open source Capital Expenditure: 10600000 Open source
20162016-12-31	Free cash flow	292900000	Operating Cash Flow: 301600000 Open source Capital Expenditure: 8700000 Open source
20172017-12-31	Free cash flow	577600000	Operating Cash Flow: 590700000 Open source Capital Expenditure: 13100000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

44.5% 2017

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	No source recorded
20162016-12-31	Liabilities / assets	22.6%	Total Liabilities: 165700000 Open source Total Assets: 731900000 Open source
20172017-12-31	Liabilities / assets	44.5%	Total Liabilities: 720700000 Open source Total Assets: 1618300000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2× 2017

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
20162016-12-31	Current assets / current liabilities	4.66×	Current Assets: 475600000 Open source Current Liabilities: 102000000 Open source
20172017-12-31	Current assets / current liabilities	2×	Current Assets: 778300000 Open source Current Liabilities: 390100000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	Unit1 108.6 million Exact value Exact value: 108600000 Unit1 2015-01-01 – 2015-12-31: 108600000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Bioverativ Inc. · 2015-12-31 Bioverativ Inc. (edgar:1681689) Net Income: 108600000 Unit1 Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: 108600000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195790 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 41.4 million Exact value Exact value: 41400000 Unit1 2015-01-01 – 2015-12-31: 41400000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bioverativ Inc. · 2015-12-31 Bioverativ Inc. (edgar:1681689) Operating Cash Flow: 41400000 Unit1 Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: 41400000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195215 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 10.6 million Exact value Exact value: 10600000 Unit1 2015-01-01 – 2015-12-31: 10600000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bioverativ Inc. · 2015-12-31 Bioverativ Inc. (edgar:1681689) Capital Expenditure: 10600000 Unit1 Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 10600000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1258791 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 30.8 million Calculation and evidence 41400000 − 10600000 Unit1 Exact free cash flow: 30800000 Unit1 2015-01-01 – 2015-12-31: 41400000 Unit1 · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 10600000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bioverativ Inc. · 2015-12-31 Bioverativ Inc. (edgar:1681689) Free cash flow: 30800000 Unit1 Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 41400000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195215 Filing: 000155837018000672 Input fundies:CapitalExpenditure: 10600000 Unit1 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1258791 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	Unit1 439.6 million Exact value Exact value: 439600000 Unit1 2016-01-01 – 2016-12-31: 439600000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Bioverativ Inc. · 2016-12-31 Bioverativ Inc. (edgar:1681689) Net Income: 439600000 Unit1 Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: 439600000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1196056 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 301.6 million Exact value Exact value: 301600000 Unit1 2016-01-01 – 2016-12-31: 301600000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bioverativ Inc. · 2016-12-31 Bioverativ Inc. (edgar:1681689) Operating Cash Flow: 301600000 Unit1 Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: 301600000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195406 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 8.7 million Exact value Exact value: 8700000 Unit1 2016-01-01 – 2016-12-31: 8700000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bioverativ Inc. · 2016-12-31 Bioverativ Inc. (edgar:1681689) Capital Expenditure: 8700000 Unit1 Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 8700000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1258982 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 292.9 million Calculation and evidence 301600000 − 8700000 Unit1 Exact free cash flow: 292900000 Unit1 2016-01-01 – 2016-12-31: 301600000 Unit1 · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 8700000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bioverativ Inc. · 2016-12-31 Bioverativ Inc. (edgar:1681689) Free cash flow: 292900000 Unit1 Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 301600000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195406 Filing: 000155837018000672 Input fundies:CapitalExpenditure: 8700000 Unit1 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1258982 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	Unit1 355.6 million Exact value Exact value: 355600000 Unit1 2017-01-01 – 2017-12-31: 355600000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · Bioverativ Inc. · 2017-12-31 Bioverativ Inc. (edgar:1681689) Net Income: 355600000 Unit1 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: 355600000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1196931 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 590.7 million Exact value Exact value: 590700000 Unit1 2017-01-01 – 2017-12-31: 590700000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bioverativ Inc. · 2017-12-31 Bioverativ Inc. (edgar:1681689) Operating Cash Flow: 590700000 Unit1 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: 590700000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195598 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 13.1 million Exact value Exact value: 13100000 Unit1 2017-01-01 – 2017-12-31: 13100000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bioverativ Inc. · 2017-12-31 Bioverativ Inc. (edgar:1681689) Capital Expenditure: 13100000 Unit1 Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 13100000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1259172 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.	Unit1 577.6 million Calculation and evidence 590700000 − 13100000 Unit1 Exact free cash flow: 577600000 Unit1 2017-01-01 – 2017-12-31: 590700000 Unit1 · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 13100000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bioverativ Inc. · 2017-12-31 Bioverativ Inc. (edgar:1681689) Free cash flow: 577600000 Unit1 Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681689?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 590700000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1195598 Filing: 000155837018000672 Input fundies:CapitalExpenditure: 13100000 Unit1 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681689/000155837018000672/bivv-20171231.xml#1259172 Filing: 000155837018000672 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

118 filings · 544 latest values · 544 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001681689, 1681689, edgar:1681689

Also known as Bioverativ Inc.

Bioverativ Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2017 2017-01-01 – 2017-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation